MapLight Therapeutics, Inc. (MPLT) Financials

MPLT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 368.3 million 20.0 million
March 31, 2026 418.8 million 19.0 million
Dec. 31, 2025 479.5 million 21.1 million
Sept. 30, 2025 257.2 million 23.7 million

MPLT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -44.9 million ?
March 31, 2026 -51.2 million 9.6 million
Dec. 31, 2025 -47.2 million 35.5 million
Sept. 30, 2025 -31.8 million 125000

MPLT Net Income

No data available :(

MPLT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 304.7 million - 755000
March 31, 2026 310.1 million - 4.7 million
Dec. 31, 2025 305.1 million - 4.9 million
Sept. 30, 2025 227.2 million - 6.0 million

MPLT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 45.4 million
March 31, 2026 45.3 million
Dec. 31, 2025 44.0 million
Sept. 30, 2025 41.4 million

MPLT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 22000 53.4 million - -
March 31, 2026 24000 53.7 million 10.8 million -
Dec. 31, 2025 376000 64.5 million 18.8 million -
Sept. 30, 2025 31000 27.1 million 4.4 million -

MPLT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 147000
March 31, 2026 - 162000
Dec. 31, 2025 - 140000
Sept. 30, 2025 - 136000

MPLT

Price: $11.23

52 week price:
9.10
40.43

Earnings Per Share: -20.95 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 548.2 million

Links: